Wright Medical Group, Inc. Announces FDA Approval for AUGMENT(R) Bone Graft
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Northland Capital Markets Remains Bullish on Wright Medical Group (WMGI) Following AUGMENT FDA Approval
September 2, 2015 9:40 AM EDTNorthland Capital Markets reiterated an Outperform rating and $32.00 price target on Wright Medical (NASDAQ: WMGI) following FDA approval of AUGMENT in hindfoot and ankle fusion with a clean label.
Analyst Mark Landy commented, "Yesterday WMGI announced FDA approval of AUGMENT in... More
Wright Medical (WMGI) Augment Approval Removes Overhang, Leerink Partners Says
September 2, 2015 6:24 AM EDTLeerink Partners analyst Richard Newitter reiterated an Outperform rating and $31 price target on Wright Medical (NASDAQ: WMGI), saying Augment approval unlocks a key growth catalyst and removes an overhang.
Newitter commented, "We expect WMGI shares to react positively following FDA... More
Wright Medical Group's (WMGI) AUGMENT Bone Graf PMA Receives FDA Approal
September 1, 2015 4:14 PM EDTWright Medical Group (NASDAQ: WMGI) announced that its BioMimetic subsidiary has received an approval order from the U.S. Food and Drug Administration (FDA) for its Premarket Approval Application (PMA) for AUGMENT Bone Graft. The approval order indicates that FDA determined that AUGMENT® Bone Graft is safe and effective as an alternative to autograft for ankle and/or hindfoot fusion indications. Wright can now initiate commercial sale and distribution of AUGMENT® Bone Graft in the U.S.
Robert Palmisano, president and chief executive officer, stated, The FDA approval of AUGMENT marks a capstone... More
Wright Medical Group (WMGI) Reports FDA Approval of AUGMENT Bone Graft
September 1, 2015 4:13 PM EDTWright Medical Group, Inc. (NASDAQ: WMGI) today announced that its BioMimetic subsidiary has received an approval order from the U.S. Food and Drug Administration (FDA) for its Premarket Approval Application (PMA) for AUGMENT® Bone Graft. The approval order indicates that FDA determined that AUGMENT® Bone Graft is safe and effective as an alternative to autograft for ankle and/or hindfoot fusion indications. Wright can now initiate commercial sale and distribution of AUGMENT® Bone Graft in the U.S.
Robert Palmisano, president and chief executive officer, stated, The FDA approval of AUGMENT marks a capstone... More
